Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Spero Therapeutics, Inc. (SPRO) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Spero Therapeutics, Inc. (SPRO), most recent 12 months reported: revenue $47M, net income $7.38M. Latest balance sheet on file: liquid cash $50.77M, total debt $91K, net cash $50.68M. From SEC filings. Others in Pharmaceutical Preparations: Q32 Bio Inc. · Siga Technologies INC · GOSSAMER BIO, INC. · OCULAR THERAPEUTIX, INC · Biofrontera Inc. · INTEGRATED BIOPHARMA INC · LEXICON PHARMACEUTICALS, INC. · BGM Group Ltd

Stock screener

Watchlist